PharmaLogic Names Etienne Montagut as President and CEO, Signaling New Growth Chapter in Radiopharmaceutical CDMO Sector

Boca Raton, FL, June 2, 2025 (PRNewswire) -- PharmaLogic Holdings Corp. has appointed Etienne Montagut, formerly of Lantheus, GE HealthCare, and Ipsen, as its new President and CEO, succeeding long-time leader Steve Chilinski, who becomes Executive Chairman. Montagut’s extensive pharmaceutical leadership experience positions him to lead PharmaLogic’s next phase of growth and transformation. With a strong global footprint and focus on innovative radiopharmaceuticals, the company is well-positioned to expand patient access to critical diagnostics and therapies.

Read full article here.